Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Frailty 2Pancreatic Neoplasms 1Neoplasms 1Hepatic Malignancies 1Gallbladder Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 20130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 7Leucovorin 7Fluorouracil 7Drug Therapy 5Taxes 4Albumin-Bound Paclitaxel 4Specimen Handling 3S 1 (combination) 3Paclitaxel 3Irinotecan 3Injections 3zimberelimab 2toripalimab 2surufatinib 2camrelizumab 2Pemetrexed 2Pancreaticoduodenectomy 2Magnetic Resonance Spectroscopy 2Exercise 2Capecitabine 2Blood Specimen Collection 2Biopsy 2zanidatamab 1trastuzumab deruxtecan 1sintilimab 1semaglutide 1potassium oxonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × Geriatric Assessment × Clear all
NCT06999512 2025-05-31

HPB70+

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Not yet recruiting
526 enrolled
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡